Package 63323-579-05

Brand: sincalide

Generic: sincalide
NDC Package

Package Facts

Identity

Package NDC 63323-579-05
Digits Only 6332357905
Product NDC 63323-579
Description

10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01)

Marketing

Marketing Status
Marketed Since 2023-04-01
Brand sincalide
Generic sincalide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7aa01e72-178a-4161-b41b-f05bc8eba1a0", "openfda": {"nui": ["M0004235", "N0000175798"], "upc": ["0363323579012"], "unii": ["M03GIQ7Z6P"], "rxcui": ["237982"], "spl_set_id": ["bb5057da-8568-49b9-947d-fab7d8d8f257"], "pharm_class_cs": ["Cholecystokinin [CS]"], "pharm_class_epc": ["Cholecystokinin Analog [EPC]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 PACKAGE (63323-579-05)  / 5 mL in 1 VIAL (63323-579-01)", "package_ndc": "63323-579-05", "marketing_start_date": "20230401"}], "brand_name": "SINCALIDE", "product_id": "63323-579_7aa01e72-178a-4161-b41b-f05bc8eba1a0", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cholecystokinin Analog [EPC]", "Cholecystokinin [CS]"], "product_ndc": "63323-579", "generic_name": "sincalide", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SINCALIDE", "active_ingredients": [{"name": "SINCALIDE", "strength": "5 ug/5mL"}], "application_number": "NDA017697", "marketing_category": "NDA", "marketing_start_date": "20230401", "listing_expiration_date": "20261231"}